Why Investors Shouldn’t Be Surprised By HansBiomed Corporation’s (KOSDAQ:042520) 29% Share Price Plunge
The HansBiomed Corporation (KOSDAQ:042520) share price has softened a substantial 29% over the previous 30 days, handing back much of the gains the stock has made lately. Of course, over the longer-term many would still wish they owned shares as the stock’s price has soared 167% in the last twelve months.
Following the heavy fall in price, HansBiomed may look like a strong buying opportunity at present with its price-to-sales (or “P/S”) ratio of 3.6x, considering almost half of all companies in the Biotechs industry in Korea have P/S ratios greater than 18.4x and even P/S higher than 114x aren’t out of the ordinary. However, the P/S might be quite low for a reason and it requires further investigation to determine if it’s…
